Ina Krämer
Novartis (Switzerland)(CH)
Publications by Year
Research Areas
Bone Metabolism and Diseases, Bone health and osteoporosis research, Bone health and treatments, Connective tissue disorders research, Wnt/β-catenin signaling in development and cancer
Most-Cited Works
- → Osteocyte Wnt/β-Catenin Signaling Is Required for Normal Bone Homeostasis(2010)563 cited
- → Bone Overgrowth-associated Mutations in the LRP4 Gene Impair Sclerostin Facilitator Function(2011)301 cited
- → Control of the SOST Bone Enhancer by PTH Using MEF2 Transcription Factors(2007)247 cited
- → Parathyroid hormone (PTH)–induced bone gain is blunted in SOST overexpressing and deficient mice(2009)244 cited
- → A Role for Runx Transcription Factor Signaling in Dorsal Root Ganglion Sensory Neuron Diversification(2006)236 cited
- → Peripheral NT3 Signaling Is Required for ETS Protein Expression and Central Patterning of Proprioceptive Sensory Afferents(2003)206 cited
- → Inhibiting the osteocyte-specific protein sclerostin increases bone mass and fracture resistance in multiple myeloma(2017)182 cited
- → Polynucleotide Probes That Target a Hypervariable Region of 16S rRNA Genes To Identify Bacterial Isolates Corresponding to Bands of Community Fingerprints(1999)160 cited
- → Phylogenetic basis for a taxonomic dissection of the genusClostridium(1999)143 cited
- → The skeletal cell‐derived molecule sclerostin drives bone marrow adipogenesis(2017)139 cited